Infusion Reactions Following Re-administration In a clinical trial of patients with moderate to severe Ps designed to assess the efficacy of long-termmaintenance therapyversus re-treatment with an induction regimen of Infliximab following disease flare, 4% (8/219) of patients in the re-treatmentind...
The long-term effects of the drug are not known. The drug may reactivate latent tuberculosis. The relationship with plasma cell dyscrasias and lymphoproliferative diseases remains unexplained. CLINICAL IMPLICATIONS: Infliximab may be used as an effective therapeutic agent for patients with sarcoidosis who...
Long-term studies will be required to characterize further the safety risks associated with TNF-α antagonists. Switching among TNF-α antagonists Although it has not been studied in patients with PsA, it has been shown in patients with RA and spondyloarthropathy that a reasonable approach to use...
" said Murdo Gordon, executive vice president of Global Commercial Operations at Amgen. "Following July's exciting launches of our two biosimilars in oncology, Avsola highlights Amgen's long-term commitment to providing more affordable biological treatment options to patients across critical...